Insulet initiates Omnipod 5 recall following 18 AE reports
Insulet estimates that the pods involved in this correction represent approximately 1.5% of annual production globally.
Featured s
Stryker still recovering from Iran-linked cyberattack
GlobalData analysts highlight that the cyberattack could problematise Stryker’s supply chain and related business operations until its impact is fully…
All Articles
Insulet initiates Omnipod 5 recall following 18 AE reports
Insulet estimates that the pods involved in this correction represent approximately 1.5% of annual production globally.
Stryker still recovering from Iran-linked cyberattack
GlobalData analysts highlight that the cyberattack could problematise Stryker’s supply chain and related business operations until its impact is fully…
Dexcom gives sneak preview of CGM technologies’ long-term health benefits for diabetics
Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, taking place…
FDA approves J&J’s TECNIS PureSee intraocular lens
The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.
Abbott reports positive FreeDM2 study results for CGM
The study was carried out at 24 clinical sites across the UK and included 303 participants.
First patient treated in Verve Medical’s hypertension pilot trial
The trial plans to include 60 participants at ten US clinical sites.
Emboline plots US-EU launch of embolic protection system following $20m fundraise
Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US and…
Olympus unveils VISERA ELITE III platform to improve surgical visualisation
The VISERA ELITE III supports various specialities, including general surgery, arthroscopy, and ENT.
Medtech industry value to be driven by infrastructure over next decade
Analysis by Houlihan Lokey suggests that healthcare institutions are favouring medical equipment that readily fits in with their existing systems.
Vitestro raises $70m to fuel blood-drawing robot’s global commercial readiness
Vitestro's ARPD blood-drawing robot gained an EU CE mark in 2024 and launched in the healthcare settings across the region…
